News
IRIC recruits Dr. Vincent Q. Trinh to be a Principal Investigator
Published on June 29, 2022
The Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal is proud to welcome aboard a new Principal Investigator in the Digital Histology and Advanced Pathology Research Unit, Dr. Vincent Q. Trinh, who will take up his position on July 1st, 2022.
Dr. Q. Trinh will also join the Department of Pathology and Cellular Biology of the Faculty of Medicine as a Clinical Associate Professor, as well as the Department of Pathology of the Centre hospitalier de l’Université de Montréal (CHUM) as a pathologist.
Works of interest
Dr. Q. Trinh’s main research interest involves the role played by fibroblasts and stellate cells in the tumor microenvironment of pancreatic cancer precursor cells.
At IRIC, the study of progenitor cell populations during oncogenesis in other types of cancers will also be at the heart of his research program. By combining cutting-edge approaches in digital morphometrics, multiplex immunohistochemistry/immunofluorescence and single cell sequencing techniques, he will aim to redefine the diagnostic approach in pathology to help prevent tumor progression by specifically targeting those well-defined cell populations.
A young scientist with the wind in his sails
Until very recently, Dr. Q. Trinh held the position of Surgery Research Instructor in the Department of Surgery of the Vanderbilt University Medical Center, in Nashville, Tennessee. He received his medical degree from the UdeM in 2014, then completed a Master’s in Biomedical Sciences (CRCHUM) and his residency in Anatomic Pathology at the UdeM in 2019. Subsequently, as a Fellow of the McLaughlin Foundation, he completed a clinical specialization in gastrointestinal and liver pathology at Vanderbilt (2019-2020), before being named as a Research Instructor at that same institution.
“Through his various fields of expertise, his different responsibilities and his innovative research projects, Dr. Vincent Q. Trinh will definitely enhance our unique model based on collaboration, multidisciplinarity and innovation”, pointed out Marc Therrien, Scientific Director of IRIC.
“We are delighted to welcome a young Investigator as promising as Dr. Vincent Q. Trinh to IRIC. We extend the warmest of welcomes and wish him all the best in his new duties. We are sure that he will make a tremendous contribution to IRIC’s mission”, added Michel Bouvier, Chief Executive Officer of IRIC.
